Botulinum Toxin: Does it have a Place in the Management of Depression?
- 91 Downloads
The opinions expressed in this article are solely those of the author and do not purport to represent the official position or policy of the US National Institutes of Health or Department of Health and Human Services.
Compliance with Ethical Standards
Conflicts of Interest
Dr. Matthew V. Rudorfer has no conflicts of interest.
- 1.Recording Academy. Artist: Bobby McFerrin. https://www.grammy.com/grammys/artists/bobby-mcferrin. Accessed 5 Jan 2018.
- 3.James W. The principles of psychology. New York: Henry Holt and Company; 1890.Google Scholar
- 6.Wollmer MA, de Boer C, Kalak N, Beck J, Götz T, Schmidt T, Hodzic M, Bayer U, Kollmann T, Kollewe K, Sönmez D, Duntsch K, Haug MD, Schedlowski M, Hatzinger M, Dressler D, Brand S, Holsboer-Trachsler E, Kruger TH. Facing depression with botulinum toxin: a randomized controlled trial. J Psychiatr Res. 2012;46:574–81.CrossRefPubMedGoogle Scholar
- 9.Patel S. OnabotulinumtoxinA as treatment for major depressive disorder in adult females. 2017. https://clinicaltrials.gov/show/NCT02116361. Accessed 31 Mar 2017.
- 10.Allergan press release. Allergan reports topline Phase II data supporting advancement of BOTOX® (onabotulinumtoxinA) for the treatment of major depressive disorder (MDD). https://www.allergan.com/News/News/Thomson-Reuters/Allergan-Reports-Topline-Phase-II-Data-Supporting. Accessed 4 May 2017.
- 12.Saunders B. CEO blog: mental illness—a growing problem that needs our focus. 2016. https://www.allergan.com/news/ceo-blog/may-2016/mental-illness. Accessed 25 May 2016.
- 14.Wilkinson ST, Ballard ED, Bloch MH, Mathew SJ, Murrough JW, Feder A, Sos P, Wang G, Zarate CA Jr, Sanacora G. The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis. Am J Psychiatry. 2017. https://doi.org/10.1176/appi.ajp.2017.17040472.PubMedCentralGoogle Scholar
- 15.Hennenlotter A, Dresel C, Castrop F, Ceballos-Baumann AO, Wohlschläger AM, Haslinger B. The link between facial feedback and neural activity within central circuitries of emotion—new insights from botulinum toxin-induced denervation of frown muscles. Cereb Cortex. 2009;19:537–42.CrossRefPubMedGoogle Scholar